# Easterly Government Properties, Inc.: financial statements, quarterly

DEA · NYSE · CIK 1622194 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dea.md) · [Financials](/companies/dea/financials.md) · [Filings](/companies/dea/filings.md) · [Insiders](/companies/dea/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dea/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [72.0](/filings/0000950170-24-121530.md) | [72.6 d](/filings/0001193125-26-064115.md) | [72.8](/filings/0000950170-25-060207.md) | [76.2](/filings/0000950170-25-103116.md) | [74.8](/filings/0001193125-25-251664.md) | [78.3 d](/filings/0001193125-26-064115.md) | [78.7](/filings/0001622194-26-000019.md) | [84.2](/filings/0001622194-26-000026.md) | [86.2](/filings/0001193125-25-251664.md) | [87.0 d](/filings/0001193125-26-064115.md) | [91.5](/filings/0001622194-26-000019.md) | [92.4](/filings/0001622194-26-000026.md) |
| Cost of revenue | $m | [18.7](/filings/0000950170-24-121530.md) | [17.7 d](/filings/0001193125-26-064115.md) | [16.6](/filings/0000950170-25-060207.md) | [18.1](/filings/0000950170-25-103116.md) | [16.7](/filings/0001193125-25-251664.md) | [18.7 d](/filings/0001193125-26-064115.md) | [17.8](/filings/0001622194-26-000019.md) | [19.2](/filings/0001622194-26-000026.md) | [20.7](/filings/0001193125-25-251664.md) | [19.8 d](/filings/0001193125-26-064115.md) | [20.5](/filings/0001622194-26-000019.md) | [20.0](/filings/0001622194-26-000026.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [5.4](/filings/0000950170-24-121530.md) | [4.4 d](/filings/0001193125-26-064115.md) | [4.6](/filings/0000950170-25-060207.md) | [4.6](/filings/0000950170-25-103116.md) | [4.9](/filings/0001193125-25-251664.md) | [5.5 d](/filings/0001193125-26-064115.md) | [3.1](/filings/0001622194-26-000019.md) | [4.1](/filings/0001622194-26-000026.md) | [1.2](/filings/0001193125-25-251664.md) | [4.6 d](/filings/0001193125-26-064115.md) | [1.4](/filings/0001622194-26-000019.md) | [3.1](/filings/0001622194-26-000026.md) |
| Diluted EPS | $ per share | [0.06](/filings/0000950170-24-121530.md) | not reported | [0.11](/filings/0000950170-25-060207.md) | [0.11](/filings/0000950170-25-103116.md) | [0.11](/filings/0001193125-25-251664.md) | not reported | [0.07](/filings/0001622194-26-000019.md) | [0.09](/filings/0001622194-26-000026.md) | [0.02](/filings/0001193125-25-251664.md) | not reported | [0.02](/filings/0001622194-26-000019.md) | [0.06](/filings/0001622194-26-000026.md) |
| Basic EPS | $ per share | [0.06](/filings/0000950170-24-121530.md) | not reported | [0.11](/filings/0000950170-25-060207.md) | [0.11](/filings/0000950170-25-103116.md) | [0.11](/filings/0001193125-25-251664.md) | not reported | [0.07](/filings/0001622194-26-000019.md) | [0.09](/filings/0001622194-26-000026.md) | [0.02](/filings/0001193125-25-251664.md) | not reported | [0.02](/filings/0001622194-26-000019.md) | [0.06](/filings/0001622194-26-000026.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.7](/filings/0000950170-23-056902.md) | [9.4](/filings/0000950170-25-026749.md) | [43.5](/filings/0000950170-24-050565.md) | [14.8](/filings/0000950170-24-088240.md) | [31.2](/filings/0000950170-24-121530.md) | [19.4](/filings/0001193125-26-064115.md) | [8.5](/filings/0000950170-25-060207.md) | [4.7](/filings/0000950170-25-103116.md) | [4.4](/filings/0001193125-25-251664.md) | [23.4](/filings/0001622194-26-000026.md) | [2.0](/filings/0001622194-26-000019.md) | [3.3](/filings/0001622194-26-000026.md) |
| Total assets | $m | [2,825](/filings/0000950170-23-056902.md) | [2,880](/filings/0000950170-25-026749.md) | [2,943](/filings/0000950170-24-050565.md) | [2,996](/filings/0000950170-24-088240.md) | [3,103](/filings/0000950170-24-121530.md) | [3,223](/filings/0001193125-26-064115.md) | [3,225](/filings/0000950170-25-060207.md) | [3,359](/filings/0000950170-25-103116.md) | [3,381](/filings/0001193125-25-251664.md) | [3,380](/filings/0001622194-26-000026.md) | [3,420](/filings/0001622194-26-000019.md) | [3,416](/filings/0001622194-26-000026.md) |
| Total liabilities | $m | [1,390](/filings/0000950170-23-056902.md) | [1,470](/filings/0000950170-25-026749.md) | [1,555](/filings/0000950170-24-050565.md) | [1,624](/filings/0000950170-24-088240.md) | [1,721](/filings/0000950170-24-121530.md) | [1,836](/filings/0001193125-26-064115.md) | [1,826](/filings/0000950170-25-060207.md) | [1,973](/filings/0000950170-25-103116.md) | [1,997](/filings/0001193125-25-251664.md) | [2,010](/filings/0001622194-26-000026.md) | [2,065](/filings/0001622194-26-000019.md) | [2,057](/filings/0001622194-26-000026.md) |
| Long-term debt | $m | [1,217](/filings/0000950170-23-056902.md) | [1,295](/filings/0000950170-25-026749.md) | [1,359](/filings/0000950170-24-050565.md) | [1,401](/filings/0000950170-24-088240.md) | [1,475](/filings/0000950170-24-121530.md) | [1,599](/filings/0001193125-26-064115.md) | [1,601](/filings/0000950170-25-060207.md) | [1,723](/filings/0000950170-25-103116.md) | [1,639](/filings/0001193125-25-251664.md) | [1,666](/filings/0001193125-26-064115.md) | [1,712](/filings/0001622194-26-000019.md) | [1,707](/filings/0001622194-26-000026.md) |
| Shareholders' equity | $m | [1,271](/filings/0000950170-23-056902.md) | [1,322](/filings/0000950170-25-026749.md) | [1,319](/filings/0000950170-24-050565.md) | [1,305](/filings/0000950170-24-088240.md) | [1,315](/filings/0000950170-24-121530.md) | [1,321](/filings/0001193125-26-064115.md) | [1,334](/filings/0000950170-25-060207.md) | [1,334](/filings/0000950170-25-103116.md) | [1,334](/filings/0001193125-25-251664.md) | [1,323](/filings/0001622194-26-000026.md) | [1,309](/filings/0001622194-26-000019.md) | [1,315](/filings/0001622194-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [37.9 d](/filings/0000950170-24-121530.md) | [17.5 d](/filings/0001193125-26-064115.md) | [23.9](/filings/0000950170-25-060207.md) | [57.0 d](/filings/0000950170-25-103116.md) | [57.2 d](/filings/0001193125-25-251664.md) | [24.6 d](/filings/0001193125-26-064115.md) | [24.2](/filings/0001622194-26-000019.md) | [38.1 d](/filings/0001622194-26-000026.md) | [155 d](/filings/0001193125-25-251664.md) | [41.9 d](/filings/0001193125-26-064115.md) | [27.3](/filings/0001622194-26-000019.md) | [44.6 d](/filings/0001622194-26-000026.md) |
| Dividends paid | $m | [28.2 d](/filings/0000950170-24-121530.md) | [28.6 d](/filings/0001193125-26-064115.md) | [28.7](/filings/0000950170-25-060207.md) | [28.8 d](/filings/0000950170-25-103116.md) | [28.9 d](/filings/0001193125-25-251664.md) | [29.5 d](/filings/0001193125-26-064115.md) | [30.2](/filings/0001622194-26-000019.md) | [21.3 d](/filings/0001622194-26-000026.md) | [21.3 d](/filings/0001193125-25-251664.md) | [21.7 d](/filings/0001193125-26-064115.md) | [21.8](/filings/0001622194-26-000019.md) | [21.9 d](/filings/0001622194-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [91.1](/filings/0000950170-23-056902.md) | [91.3](/filings/0000950170-24-050565.md) | [93.6](/filings/0000950170-24-088240.md) | [93.8](/filings/0000950170-24-121530.md) | [40.9](/filings/0000950170-25-060207.md) | [41.3](/filings/0000950170-25-103116.md) | [41.6](/filings/0001193125-25-251664.md) | [43.4](/filings/0001622194-26-000019.md) | [45.1](/filings/0001622194-26-000026.md) | [45.5](/filings/0001193125-25-251664.md) | [46.5](/filings/0001622194-26-000019.md) | [46.7](/filings/0001622194-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,321,617 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001622194-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.